Clinical Biosafety Services, a subsidiary of Sabai Global Email Format
Biotechnology ResearchMissouri, United States11-50 Employees
Clinical Biosafety Services, a subsidiary of Sabai Global, operates in the biotechnology research sector with a focus on gene therapy review and biosafety consulting. Based in Chesterfield, Missouri, the company serves institutions and sponsors by providing accelerated, compliant reviews for site-specific Institutional Biosafety Committees (IBCs), aiming to streamline the regulatory process for gene transfer and gene therapy clinical trials. Its work addresses the needs of organizations navigating complex biosafety review requirements, reducing regulatory burden and uncertainty while supporting trial enrollment. The business targets research and clinical programs involved in gene therapy, positioning itself as a specialized service within the institutional biosafety and biosafety consulting landscape. The firm emphasizes timely, expert guidance through the IBC review process to advance therapeutic research in a compliant manner.